PGT / Genetic Testing in Saket: Complete Guide for Delhi Families

Preimplantation Genetic Testing is not a single test but a family of advanced diagnostics applied to embryos created through IVF. PGT-A (Aneuploidy) checks whether an embryo carries the correct number of chromosomes—24-chromosome screening using next-generation sequencing (NGS) is the current gold standard. PGT-M (Monogenic) targets specific single-gene disorders such as thalassaemia, sickle-cell anaemia, cystic fibrosis, or BRCA-related mutations. PGT-SR (Structural Rearrangements) is used when one or both partners carry a chromosomal translocation.

For Saket families, this matters enormously. Delhi's cosmopolitan population includes many carrier couples—individuals who carry one copy of a recessive genetic mutation without being affected themselves. When two carriers conceive, each pregnancy carries a 25% chance of the child inheriting two mutated copies and being affected. Genetic testing of embryos before transfer eliminates this risk by allowing clinicians to select only unaffected embryos.

The HomeIVF Medical Board emphasises that genetic counselling should always precede testing. Understanding what the results mean, how they will guide clinical decisions, and what happens if all embryos are affected is vital before beginning the process. HomeIVF provides this counselling as part of its integrated care pathway, accessible from the comfort of your Saket home.

Understanding the genetic testing journey helps Saket patients approach the process with confidence. The pathway typically unfolds as follows.

Step 1 — Ovarian Stimulation: Hormone injections stimulate the ovaries to produce multiple follicles over 10 to 14 days. HomeIVF nurses can administer or supervise injections at your Saket residence, reducing the need for daily clinic visits.

Step 2 — Egg Retrieval: Performed under short sedation at a partnered facility, eggs are collected and fertilised with sperm in the laboratory to create embryos.

Step 3 — Embryo Culture: Embryos are cultured for 5 to 6 days until they reach the blastocyst stage, the optimal point for biopsy.

Step 4 — Trophectoderm Biopsy: A few cells are carefully removed from the outer layer (trophectoderm) of each blastocyst. This does not harm the inner cell mass that becomes the baby.

Step 5 — Genetic Analysis: Biopsied cells are sent to a certified genetic laboratory. Using NGS or array-CGH platforms, technicians analyse chromosomal composition or target specific mutations depending on the type of PGT ordered.

Step 6 — Embryo Vitrification: All biopsied embryos are frozen while awaiting results.

Step 7 — Transfer of Euploid Embryo: Once results are available, a chromosomally normal (euploid) embryo is transferred in a subsequent frozen embryo transfer (FET) cycle.

HomeIVF coordinates every step, from monitoring calls to result interpretation, keeping Saket patients informed throughout.

Not every IVF patient requires genetic testing, but there are well-established clinical indications where the HomeIVF Medical Board strongly recommends consideration of PGT.

Advanced Maternal Age (AMA): Women aged 35 and above produce a higher proportion of aneuploid eggs. By 40, studies suggest more than half of embryos may carry chromosomal errors. PGT-A helps identify the viable minority, making each transfer attempt more purposeful.

Recurrent Implantation Failure (RIF): Couples who have experienced two or more failed IVF transfers with good-quality embryos are prime candidates. Chromosomal abnormality in embryos is a leading—and often undetected—cause of implantation failure.

Recurrent Pregnancy Loss (RPL): If you have suffered two or more miscarriages, chromosomal errors in embryos are frequently responsible. PGT-A screening can break the cycle of loss.

Known Genetic Carrier Status: If either partner has been identified as a carrier of a monogenic condition—particularly relevant in communities with higher carrier frequencies for thalassaemia or G6PD deficiency—PGT-M is the appropriate investigation.

Severe Male Factor Infertility: Men with very low sperm counts or structural chromosomal abnormalities (such as translocations) may pass these on to embryos; PGT-SR evaluates this risk directly.

For Saket residents, where both partners are often working professionals with limited leave, maximising the probability of success per transfer is both medically and practically important. The HomeIVF Medical Board tailors recommendations to each couple's unique clinical and personal profile.

When comparing genetic testing options in Delhi, Saket patients often discover significant variation in what is actually included in a quoted price. Many standalone fertility clinics in Delhi bill for ovarian stimulation, egg retrieval, embryo culture, biopsy, laboratory analysis, embryo vitrification, and FET cycle as separate line items, making the final bill unpredictable and sometimes stressful.

HomeIVF takes a different approach. Packages starting from ₹1.5 lakh are structured to include co-ordinated care across the full cycle, with transparent inclusions communicated upfront. The HomeIVF model integrates at-home monitoring visits, teleconsultation with board-certified specialists, medication guidance, and dedicated care coordination—elements that typical walk-in Delhi clinics charge for separately or do not offer at all.

Clinically, HomeIVF partners exclusively with NABL-accredited and internationally benchmarked genetic laboratories for PGT analysis, ensuring that results meet the highest standards for clinical decision-making. Embryology is performed at state-of-the-art partner facilities, while the surrounding consultative and monitoring care is delivered at home.

For Saket families who value both clinical rigour and personal attention, the HomeIVF model represents a meaningfully different experience from the crowded waiting rooms of large hospital fertility departments—without compromising on the science.

Saket sits at the intersection of South Delhi's busiest corridors. Getting to Vasant Kunj, Lajpat Nagar, or even Hauz Khas during peak hours can consume an hour or more each way—time that working professionals, parents of young children, or individuals managing health conditions simply cannot afford to lose repeatedly over a fertility treatment cycle that involves multiple monitoring appointments.

HomeIVF's at-home care model was designed precisely for residents like those in Saket. Hormone monitoring blood draws, ultrasound co-ordination referrals, injection teaching sessions, and counselling calls all happen at a time and location that suits you. This is not a convenience add-on—it is a clinically validated model that improves medication adherence, reduces treatment-related stress, and supports better outcomes.

Privacy is another key consideration. Fertility treatment remains sensitive in many families, and the discretion of receiving a HomeIVF nurse or counsellor at your Saket residence—rather than being seen at a recognisable fertility clinic—matters to many couples. The HomeIVF Medical Board ensures that all home visits are conducted by trained, credentialled professionals operating under strict confidentiality protocols.

Senior specialist oversight is maintained throughout via teleconsultation, meaning Saket patients receive the same quality of clinical decision-making as those physically present in a top Delhi hospital—without the commute, crowds, or compromise.

Saket is one of Delhi's most well-connected residential and commercial hubs. The Saket Metro Station on the Yellow Line provides easy access to the rest of Delhi, and the locality sits close to the Outer Ring Road and Mehrauli-Badarpur Road, making travel to partner diagnostic and surgical facilities straightforward when in-person procedures are needed.

For PGT cycles specifically, the two in-person touchpoints that cannot be done at home are the egg retrieval procedure and the embryo transfer. HomeIVF's partner facilities are selected for their proximity to major residential clusters including Saket, ensuring minimal travel on the days that matter most. Patients are provided with precise logistics support—appointment scheduling, facility directions, and pre-procedure checklists—as part of the HomeIVF care package.

The presence of Max Super Speciality Hospital and the Apollo Hospitals cluster in and around Saket means the locality already has a strong diagnostic infrastructure. HomeIVF integrates with this ecosystem rather than competing with it, allowing Saket patients to combine the strengths of established hospital-grade facilities with the personalised, technology-enabled coordination that HomeIVF provides.

For couples living in sectors adjacent to Saket—including Malviya Nagar, Sheikh Sarai, and Pushp Vihar—HomeIVF's service reach extends to cover these neighbourhoods without additional logistics complexity.

Genetic testing as part of IVF remains largely outside the scope of standard health insurance coverage in India, a reality that Saket patients should plan for proactively. Most group health insurance policies and individual mediclaim plans exclude assisted reproductive technologies including IVF, ICSI, and PGT. However, a small and growing number of corporate health plans—particularly those offered by technology and financial sector employers well-represented in Saket—are beginning to offer fertility benefits riders. Patients are advised to review their policy documents carefully or speak with their HR benefits team.

HomeIVF supports financial accessibility through EMI options facilitated via lending partners, allowing the cost of treatment to be distributed over manageable monthly instalments rather than paid as a single lump sum. The HomeIVF patient services team can walk Saket families through available financing options during the initial consultation.

From a planning standpoint, couples considering PGT should budget for the possibility that multiple stimulation cycles may be needed to produce sufficient embryos for testing—particularly in cases of diminished ovarian reserve or advanced maternal age. The HomeIVF Medical Board provides personalised prognostic counselling so that financial planning is grounded in realistic expectations rather than best-case assumptions.

Documentation of carrier status or a clinical diagnosis supporting PGT-M may also be useful for future insurance negotiations as policy frameworks evolve in Delhi and nationally.

Beginning your PGT journey with HomeIVF from Saket is a straightforward process designed to minimise friction and maximise clinical value from the very first interaction.

Step 1 — Book a Free Consultation: Visit HomeIVF.com and select your location as Saket, Delhi. A patient coordinator will contact you within 24 hours to schedule a video or phone consultation at your preferred time.

Step 2 — Initial Assessment: The consultation covers your medical history, any previous fertility investigations or treatments, family history relevant to genetic conditions, and your personal and professional circumstances—including the commute and privacy factors that matter to Saket residents.

Step 3 — Personalised Recommendation: Based on your assessment, the HomeIVF Medical Board will determine whether PGT-A, PGT-M, PGT-SR, or a combination is clinically appropriate, and will outline your proposed treatment pathway with full transparency on what is included.

Step 4 — At-Home Onboarding: Once you decide to proceed, a HomeIVF nurse visits your Saket home to complete baseline investigations, provide medication training, and establish your monitoring schedule.

Step 5 — Ongoing Care and Communication: A dedicated care coordinator remains your single point of contact throughout the cycle, available via the HomeIVF app for questions, updates, and appointment management.

The entire process is designed so that Saket residents feel supported, informed, and in control at every stage of their fertility journey.